[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100334689":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":10,"responsibleParty":26,"collaborators":30,"id":91,"slug":92,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":95,"acronym":96,"eligibilityCriteria":97,"healthyVolunteers":98,"sex":99,"minAge":10,"maxAge":100,"enrollmentInfo":101,"targetDuration":10,"studyType":104,"phases":10,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":110,"whyStopped":10,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":10},{"fullName":5,"class":6},"Sun Yat-sen University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"NPC survivors",null,"Survivors of NPC, diagnosed under 21 years of age, between 1990 and 2030. This project will study children and young adults exposed to specific therapeutic modalities, including radiation, chemotherapy, and\u002For surgery, for an increased risk of late-occurring events associated with excess mortality and morbidity.",{"label":13,"type":10,"description":14,"interventionNames":10},"Sibling Controls","A group of sibling controls will be identified to provide: (1) the ability to make direct comparisons with the survivors, (2) data on outcomes in a non-cancer population, and (3) additional comparison group to determine the consistency of findings between data sources.",[16],{"name":17,"affiliation":18,"role":19},"Hai Mai, Dr","Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center","STUDY_CHAIR",[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Haiqiang Mai, Dr","CONTACT","86-20-8734-3643","maihq@mail.sysu.edu.cn",{"type":27,"investigatorFullName":28,"investigatorTitle":29,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Hai-Qiang Mai,MD,PhD","Hai-Qiang Mai",[31,33,35,37,39,41,44,46,48,51,53,55,57,59,61,63,65,67,69,71,73,75,77,79,81,83,85,87,89],{"name":32,"class":6},"Affiliated Cancer Hospital & Institute of Guangzhou Medical University",{"name":34,"class":6},"Guangdong Provincial People's Hospital",{"name":36,"class":6},"First Affiliated Hospital of Jinan University",{"name":38,"class":6},"Nanfang Hospital, Southern Medical University",{"name":40,"class":6},"Affiliated Cancer Hospital of Shantou University Medical College",{"name":42,"class":43},"Zhanjiang Cancer Hospital","UNKNOWN",{"name":45,"class":6},"Zhongnan Hospital",{"name":47,"class":6},"First People's Hospital of Foshan",{"name":49,"class":50},"Dongguan People's Hospital","OTHER_GOV",{"name":52,"class":6},"Fifth Affiliated Hospital, Sun Yat-Sen University",{"name":54,"class":6},"Shenzhen Second People's Hospital",{"name":56,"class":6},"Jiangmen Central Hospital",{"name":58,"class":6},"Yuebei People's Hospital",{"name":60,"class":6},"Hunan Cancer Hospital",{"name":62,"class":6},"Cancer Hospital of Guizhou Province",{"name":64,"class":6},"Fudan University",{"name":66,"class":50},"Fujian Cancer Hospital",{"name":68,"class":6},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",{"name":70,"class":6},"The First Affiliated Hospital of Zhengzhou University",{"name":72,"class":6},"Zhejiang Cancer Hospital",{"name":74,"class":6},"Sichuan Cancer Hospital and Research Institute",{"name":76,"class":6},"Shandong Cancer Hospital and Institute",{"name":78,"class":6},"Jiangsu Cancer Institute & Hospital",{"name":80,"class":6},"Jiangxi Provincial Cancer Hospital",{"name":82,"class":6},"Second Affiliated Hospital of Nanchang University",{"name":84,"class":6},"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",{"name":86,"class":6},"Peking University Cancer Hospital & Institute",{"name":88,"class":6},"Cancer Hospital of Guangxi Medical University",{"name":90,"class":6},"Tongji Hospital","100334689","the-children-and-adolescents-nasopharyngeal-carcinoma-survivor-study-100334689",false,"NCT03637634","The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study","CANPCSS","Inclusion Criteria:\n\n* Patients or their siblings must be informed of the investigational nature of this study and give written informed consent.\n\n  * Patients with histologically confirmed non-keratinizing nasopharyngeal carcinoma (including differentiated type and undifferentiated type, WHO II or III) before age 21 years at one of participating centers.\n\nExclusion Criteria:\n\n* Already involved in other blind clinical trial.\n* The information of tumour response evaluation and survival data cannot be obtained.",true,"ALL","21 Years",{"count":102,"type":103},1000,"ESTIMATED","OBSERVATIONAL","The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study will investigate the long-term effects of nasopharyngeal carcinoma (NPC) and its associated therapies. A prospective and retrospective cohort study will be conducted through a multi-institutional collaboration. This project will study children and adolescents exposed to specific therapeutic modalities, including radiation, chemotherapy, and\u002For surgery, who are at increased risk of late-occurring adverse health outcomes. A group of sibling controls will be identified and data collected for comparison purposes.",[107],"NPC Patients",[109],"children and adolescents","NOT_YET_RECRUITING","2018-08-26",{"date":113,"type":114},"2018-08-28","ACTUAL",{"date":116,"type":103},"2018-09-01",{"date":118,"type":103},"2035-12-31",{"name":28,"class":6}]